Cargando…
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
INTRODUCTION: Pseudomonas aeruginosa frequently causes nosocomial pneumonia and is associated with poor outcome. The purpose of this study was to assess the prevalence and clinical outcome of nosocomial pneumonia caused by serotype-specific P. aeruginosa in critically ill patients under appropriate...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057348/ https://www.ncbi.nlm.nih.gov/pubmed/24428878 http://dx.doi.org/10.1186/cc13697 |
_version_ | 1782320947353616384 |
---|---|
author | Lu, Qin Eggimann, Philippe Luyt, Charles-Edouard Wolff, Michel Tamm, Michael François, Bruno Mercier, Emmanuelle Garbino, Jorge Laterre, Pierre-François Koch, Holger Gafner, Verena Rudolf, Michael P Mus, Erkan Perez, Antonio Lazar, Hedvika Chastre, Jean Rouby, Jean-Jacques |
author_facet | Lu, Qin Eggimann, Philippe Luyt, Charles-Edouard Wolff, Michel Tamm, Michael François, Bruno Mercier, Emmanuelle Garbino, Jorge Laterre, Pierre-François Koch, Holger Gafner, Verena Rudolf, Michael P Mus, Erkan Perez, Antonio Lazar, Hedvika Chastre, Jean Rouby, Jean-Jacques |
author_sort | Lu, Qin |
collection | PubMed |
description | INTRODUCTION: Pseudomonas aeruginosa frequently causes nosocomial pneumonia and is associated with poor outcome. The purpose of this study was to assess the prevalence and clinical outcome of nosocomial pneumonia caused by serotype-specific P. aeruginosa in critically ill patients under appropriate antimicrobial therapy management. METHODS: A retrospective, non-interventional epidemiological multicenter cohort study involving 143 patients with confirmed nosocomial pneumonia caused by P. aeruginosa. Patients were analyzed for a period of 30 days from time of nosocomial pneumonia onset. Fourteen patients fulfilling the same criteria from a phase IIa studyconducted at the same time/centers were included in the prevalence calculations but not in the clinical outcome analysis. RESULTS: The prevalence of serotypes was: O6 (29%), O11 (23%), O10 (10%), O2 (9%), and O1 (8%). Serotypes with a prevalence of less than 5% were found in 13% of patients, 8% were classified as not typeable. Across all serotypes, 19% mortality, 70% clinical resolution, 11% clinical continuation, and 5% clinical recurrence were recorded. Age and higher APACHE II (Acute Physiology and Chronic Health Evaluation II) were predictive risk factors associated with probability of death and lower clinical resolution for P. aeruginosa nosocomial pneumonia. Mortality tends to be higher with O1 (40%) and lower with O2 (0%); clinical resolution tends to be better with O2 (82%) compared to other serotypes. Persisting pneumonia with O6 and O11 was, respectively, 8% and 21%; clinical resolution with O6 and O11 was, respectively, 75% and 57%. CONCLUSIONS: In P. aeruginosa nosocomial pneumonia, the most prevalent serotypes were O6 and O11. Further studies including larger group sizes are needed to correlate clinical outcome with virulence factors of P. aeruginosa in patients with nosocomial pneumonia caused by various serotypes; and to compare O6 and O11, the two serotypes most frequently encountered in critically ill patients. |
format | Online Article Text |
id | pubmed-4057348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40573482014-06-14 Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes Lu, Qin Eggimann, Philippe Luyt, Charles-Edouard Wolff, Michel Tamm, Michael François, Bruno Mercier, Emmanuelle Garbino, Jorge Laterre, Pierre-François Koch, Holger Gafner, Verena Rudolf, Michael P Mus, Erkan Perez, Antonio Lazar, Hedvika Chastre, Jean Rouby, Jean-Jacques Crit Care Research INTRODUCTION: Pseudomonas aeruginosa frequently causes nosocomial pneumonia and is associated with poor outcome. The purpose of this study was to assess the prevalence and clinical outcome of nosocomial pneumonia caused by serotype-specific P. aeruginosa in critically ill patients under appropriate antimicrobial therapy management. METHODS: A retrospective, non-interventional epidemiological multicenter cohort study involving 143 patients with confirmed nosocomial pneumonia caused by P. aeruginosa. Patients were analyzed for a period of 30 days from time of nosocomial pneumonia onset. Fourteen patients fulfilling the same criteria from a phase IIa studyconducted at the same time/centers were included in the prevalence calculations but not in the clinical outcome analysis. RESULTS: The prevalence of serotypes was: O6 (29%), O11 (23%), O10 (10%), O2 (9%), and O1 (8%). Serotypes with a prevalence of less than 5% were found in 13% of patients, 8% were classified as not typeable. Across all serotypes, 19% mortality, 70% clinical resolution, 11% clinical continuation, and 5% clinical recurrence were recorded. Age and higher APACHE II (Acute Physiology and Chronic Health Evaluation II) were predictive risk factors associated with probability of death and lower clinical resolution for P. aeruginosa nosocomial pneumonia. Mortality tends to be higher with O1 (40%) and lower with O2 (0%); clinical resolution tends to be better with O2 (82%) compared to other serotypes. Persisting pneumonia with O6 and O11 was, respectively, 8% and 21%; clinical resolution with O6 and O11 was, respectively, 75% and 57%. CONCLUSIONS: In P. aeruginosa nosocomial pneumonia, the most prevalent serotypes were O6 and O11. Further studies including larger group sizes are needed to correlate clinical outcome with virulence factors of P. aeruginosa in patients with nosocomial pneumonia caused by various serotypes; and to compare O6 and O11, the two serotypes most frequently encountered in critically ill patients. BioMed Central 2014-01-15 2014 /pmc/articles/PMC4057348/ /pubmed/24428878 http://dx.doi.org/10.1186/cc13697 Text en © Lu et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lu, Qin Eggimann, Philippe Luyt, Charles-Edouard Wolff, Michel Tamm, Michael François, Bruno Mercier, Emmanuelle Garbino, Jorge Laterre, Pierre-François Koch, Holger Gafner, Verena Rudolf, Michael P Mus, Erkan Perez, Antonio Lazar, Hedvika Chastre, Jean Rouby, Jean-Jacques Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes |
title | Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes |
title_full | Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes |
title_fullStr | Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes |
title_full_unstemmed | Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes |
title_short | Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes |
title_sort | pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057348/ https://www.ncbi.nlm.nih.gov/pubmed/24428878 http://dx.doi.org/10.1186/cc13697 |
work_keys_str_mv | AT luqin pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT eggimannphilippe pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT luytcharlesedouard pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT wolffmichel pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT tammmichael pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT francoisbruno pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT mercieremmanuelle pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT garbinojorge pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT laterrepierrefrancois pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT kochholger pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT gafnerverena pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT rudolfmichaelp pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT muserkan pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT perezantonio pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT lazarhedvika pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT chastrejean pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes AT roubyjeanjacques pseudomonasaeruginosaserotypesinnosocomialpneumoniaprevalenceandclinicaloutcomes |